| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
12,270 |
11,104 |
$492K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,058 |
2,699 |
$126K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
706 |
661 |
$70K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,642 |
1,529 |
$59K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,121 |
10,266 |
$46K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,122 |
1,037 |
$41K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
6,884 |
5,821 |
$38K |
| 80053 |
Comprehensive metabolic panel |
5,235 |
4,368 |
$35K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,374 |
1,031 |
$34K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,946 |
1,548 |
$26K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
674 |
536 |
$17K |
| 71045 |
Radiologic examination, chest; single view |
1,121 |
937 |
$14K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
634 |
489 |
$13K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
485 |
445 |
$13K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
228 |
207 |
$12K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
663 |
596 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
349 |
329 |
$10K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
323 |
297 |
$9K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
323 |
297 |
$9K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
215 |
42 |
$9K |
| 87400 |
|
1,031 |
502 |
$9K |
| 84443 |
Thyroid stimulating hormone (TSH) |
763 |
723 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
918 |
867 |
$8K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
127 |
114 |
$7K |
| 87081 |
|
804 |
760 |
$7K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
731 |
528 |
$6K |
| 87420 |
|
456 |
429 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
404 |
369 |
$4K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
45 |
39 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
478 |
421 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
635 |
576 |
$3K |
| 80061 |
Lipid panel |
478 |
447 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
53 |
52 |
$3K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
107 |
33 |
$3K |
| 83655 |
|
218 |
217 |
$3K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
198 |
176 |
$3K |
| 84439 |
|
409 |
381 |
$3K |
| 81001 |
|
1,136 |
984 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
182 |
132 |
$2K |
| 83690 |
|
608 |
495 |
$2K |
| G0378 |
Hospital observation service, per hour |
31 |
13 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
210 |
195 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
24 |
24 |
$2K |
| 84484 |
|
277 |
181 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
144 |
139 |
$2K |
| 83605 |
|
173 |
140 |
$2K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
50 |
49 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
139 |
85 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
89 |
81 |
$1K |
| 87807 |
|
100 |
94 |
$1K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
32 |
32 |
$1K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
41 |
40 |
$1K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
76 |
68 |
$1K |
| 88142 |
|
58 |
58 |
$1K |
| 86780 |
|
72 |
64 |
$1K |
| 86850 |
|
150 |
134 |
$1K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
14 |
12 |
$954.86 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
57 |
18 |
$933.67 |
| 86140 |
|
129 |
118 |
$865.39 |
| 85027 |
|
88 |
80 |
$862.49 |
| 94664 |
|
59 |
51 |
$781.98 |
| 70450 |
Computed tomography, head or brain; without contrast material |
13 |
13 |
$768.10 |
| 99215 |
Prolong outpt/office vis |
201 |
181 |
$745.67 |
| 36415 |
Collection of venous blood by venipuncture |
11,466 |
9,977 |
$722.11 |
| 87077 |
|
72 |
70 |
$637.88 |
| 87070 |
|
130 |
122 |
$571.57 |
| 86901 |
|
105 |
94 |
$510.42 |
| 81025 |
|
70 |
66 |
$495.55 |
| 83970 |
|
42 |
42 |
$478.11 |
| 74018 |
|
46 |
44 |
$462.63 |
| 97161 |
|
13 |
12 |
$446.95 |
| 87186 |
|
46 |
45 |
$439.87 |
| 73610 |
|
35 |
30 |
$433.23 |
| 86900 |
|
105 |
94 |
$404.16 |
| 87340 |
|
28 |
28 |
$383.90 |
| 86762 |
|
59 |
52 |
$378.29 |
| 85610 |
|
91 |
80 |
$355.89 |
| 86738 |
|
48 |
44 |
$334.10 |
| 84703 |
|
52 |
50 |
$327.76 |
| 74019 |
|
19 |
19 |
$313.88 |
| 73630 |
|
18 |
17 |
$309.45 |
| 81003 |
|
283 |
252 |
$305.77 |
| 82570 |
|
80 |
79 |
$246.88 |
| 86803 |
|
14 |
14 |
$219.43 |
| 83735 |
|
42 |
31 |
$205.45 |
| 73030 |
|
14 |
12 |
$187.08 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
339 |
267 |
$162.47 |
| 87045 |
|
12 |
12 |
$153.34 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
158 |
127 |
$125.38 |
| 84156 |
|
54 |
51 |
$102.88 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
589 |
483 |
$70.98 |
| 85018 |
|
36 |
36 |
$61.44 |
| 85651 |
|
12 |
12 |
$43.26 |
| 85014 |
|
24 |
24 |
$39.33 |
| 84550 |
|
14 |
12 |
$39.30 |
| 84100 |
|
16 |
16 |
$37.92 |
| 87427 |
|
16 |
12 |
$35.44 |
| 82248 |
|
15 |
13 |
$33.04 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
62 |
43 |
$32.09 |
| 82043 |
|
12 |
12 |
$25.90 |
| J2704 |
Injection, propofol, 10 mg |
184 |
123 |
$24.40 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
120 |
103 |
$10.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
173 |
152 |
$3.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
22 |
12 |
$0.30 |
| G0008 |
Administration of influenza virus vaccine |
33 |
28 |
$0.01 |
| 90662 |
|
12 |
12 |
$0.00 |
| 82077 |
|
15 |
13 |
$0.00 |
| A9270 |
Non-covered item or service |
113 |
42 |
$0.00 |
| 90686 |
|
14 |
14 |
$0.00 |
| 80050 |
General health panel |
15 |
15 |
$0.00 |